Skip to main content
. 2016 Jan 7;4:e1542. doi: 10.7717/peerj.1542

Figure 6. Dose Reduction Index (DRI) of cisplatin (CIS).

Figure 6

L-Canavanine (L-CAV) was combined with CIS using a constant ratio in two types of cells, cells with high ASS expression (HeLa and Caco-2) and cells with low ASS expression (MIA PaCa-2, BxPC-3, Hep G2, and SK-HEP-1).